feed,title,long_url,short_url
SeekingAlpha,BofA sees downside risk to Clarivate's 3-year turnaround plan; cuts rating and PT,https://seekingalpha.com/news/3998137,
SeekingAlpha,Vistagen social anxiety nasal spray meets phase 3 primary endpoint,https://seekingalpha.com/news/3998123,
